nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—XDH—Azathioprine—Crohn's disease	0.463	0.5	CbGbCtD
Deferoxamine—XDH—Mercaptopurine—Crohn's disease	0.463	0.5	CbGbCtD
Deferoxamine—Hepatic impairment—Mesalazine—Crohn's disease	0.00508	0.069	CcSEcCtD
Deferoxamine—Urine color abnormal—Mesalazine—Crohn's disease	0.00394	0.0535	CcSEcCtD
Deferoxamine—Chromaturia—Mesalazine—Crohn's disease	0.0026	0.0353	CcSEcCtD
Deferoxamine—Rash generalised—Mesalazine—Crohn's disease	0.00218	0.0297	CcSEcCtD
Deferoxamine—Growth retardation—Prednisone—Crohn's disease	0.00216	0.0294	CcSEcCtD
Deferoxamine—Lung infiltration—Mesalazine—Crohn's disease	0.00198	0.0269	CcSEcCtD
Deferoxamine—Local reaction—Mesalazine—Crohn's disease	0.00168	0.0228	CcSEcCtD
Deferoxamine—Transaminases increased—Mesalazine—Crohn's disease	0.00152	0.0207	CcSEcCtD
Deferoxamine—Liver disorder—Mesalazine—Crohn's disease	0.00136	0.0185	CcSEcCtD
Deferoxamine—Scotoma—Mesalazine—Crohn's disease	0.00122	0.0166	CcSEcCtD
Deferoxamine—Blood disorder—Mesalazine—Crohn's disease	0.00111	0.0151	CcSEcCtD
Deferoxamine—Bone disorder—Mesalazine—Crohn's disease	0.00103	0.014	CcSEcCtD
Deferoxamine—Neuropathy—Mesalazine—Crohn's disease	0.000871	0.0118	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000852	0.0116	CcSEcCtD
Deferoxamine—Hepatic function abnormal—Azathioprine—Crohn's disease	0.000846	0.0115	CcSEcCtD
Deferoxamine—Optic neuritis—Prednisone—Crohn's disease	0.000798	0.0108	CcSEcCtD
Deferoxamine—Immune system disorder—Mercaptopurine—Crohn's disease	0.000775	0.0105	CcSEcCtD
Deferoxamine—Renal failure acute—Mesalazine—Crohn's disease	0.000729	0.00991	CcSEcCtD
Deferoxamine—Renal impairment—Mesalazine—Crohn's disease	0.000708	0.00962	CcSEcCtD
Deferoxamine—Delusion—Prednisone—Crohn's disease	0.000693	0.00943	CcSEcCtD
Deferoxamine—Leukopenia—Mercaptopurine—Crohn's disease	0.000669	0.00909	CcSEcCtD
Deferoxamine—Arthralgia—Mercaptopurine—Crohn's disease	0.000636	0.00865	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000632	0.00859	CcSEcCtD
Deferoxamine—Blood creatinine increased—Mesalazine—Crohn's disease	0.000631	0.00858	CcSEcCtD
Deferoxamine—Abdominal discomfort—Azathioprine—Crohn's disease	0.000613	0.00833	CcSEcCtD
Deferoxamine—Oedema—Mercaptopurine—Crohn's disease	0.00061	0.00829	CcSEcCtD
Deferoxamine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000597	0.00812	CcSEcCtD
Deferoxamine—Skin disorder—Mercaptopurine—Crohn's disease	0.000592	0.00805	CcSEcCtD
Deferoxamine—Asthma—Mesalazine—Crohn's disease	0.000582	0.00791	CcSEcCtD
Deferoxamine—Eosinophilia—Mesalazine—Crohn's disease	0.000576	0.00783	CcSEcCtD
Deferoxamine—Infestation NOS—Azathioprine—Crohn's disease	0.00057	0.00774	CcSEcCtD
Deferoxamine—Infestation—Azathioprine—Crohn's disease	0.00057	0.00774	CcSEcCtD
Deferoxamine—Abdominal discomfort—Mesalazine—Crohn's disease	0.000558	0.00758	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000556	0.00755	CcSEcCtD
Deferoxamine—Dysuria—Mesalazine—Crohn's disease	0.000544	0.0074	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000526	0.00716	CcSEcCtD
Deferoxamine—Infestation NOS—Mesalazine—Crohn's disease	0.000519	0.00705	CcSEcCtD
Deferoxamine—Infestation—Mesalazine—Crohn's disease	0.000519	0.00705	CcSEcCtD
Deferoxamine—Cataract—Prednisone—Crohn's disease	0.000516	0.00701	CcSEcCtD
Deferoxamine—Renal failure—Mesalazine—Crohn's disease	0.00051	0.00693	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000509	0.00691	CcSEcCtD
Deferoxamine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000482	0.00655	CcSEcCtD
Deferoxamine—Immune system disorder—Azathioprine—Crohn's disease	0.000462	0.00628	CcSEcCtD
Deferoxamine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000461	0.00627	CcSEcCtD
Deferoxamine—Neuropathy—Prednisone—Crohn's disease	0.000461	0.00626	CcSEcCtD
Deferoxamine—Urinary tract disorder—Mesalazine—Crohn's disease	0.00046	0.00625	CcSEcCtD
Deferoxamine—Connective tissue disorder—Mesalazine—Crohn's disease	0.000458	0.00622	CcSEcCtD
Deferoxamine—Arrhythmia—Azathioprine—Crohn's disease	0.000457	0.00621	CcSEcCtD
Deferoxamine—Urethral disorder—Mesalazine—Crohn's disease	0.000457	0.00621	CcSEcCtD
Deferoxamine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000449	0.00611	CcSEcCtD
Deferoxamine—Eye disorder—Mesalazine—Crohn's disease	0.000435	0.00592	CcSEcCtD
Deferoxamine—Tinnitus—Mesalazine—Crohn's disease	0.000434	0.0059	CcSEcCtD
Deferoxamine—Angiopathy—Mesalazine—Crohn's disease	0.000423	0.00575	CcSEcCtD
Deferoxamine—Immune system disorder—Mesalazine—Crohn's disease	0.000421	0.00572	CcSEcCtD
Deferoxamine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00042	0.00571	CcSEcCtD
Deferoxamine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000417	0.00567	CcSEcCtD
Deferoxamine—Erythema—Mesalazine—Crohn's disease	0.000406	0.00551	CcSEcCtD
Deferoxamine—Leukopenia—Azathioprine—Crohn's disease	0.000399	0.00542	CcSEcCtD
Deferoxamine—Muscle spasms—Mesalazine—Crohn's disease	0.00039	0.0053	CcSEcCtD
Deferoxamine—Vomiting—Mercaptopurine—Crohn's disease	0.000388	0.00527	CcSEcCtD
Deferoxamine—Vision blurred—Mesalazine—Crohn's disease	0.000382	0.0052	CcSEcCtD
Deferoxamine—Myalgia—Azathioprine—Crohn's disease	0.000379	0.00515	CcSEcCtD
Deferoxamine—Arthralgia—Azathioprine—Crohn's disease	0.000379	0.00515	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000376	0.00512	CcSEcCtD
Deferoxamine—Angioedema—Mesalazine—Crohn's disease	0.000371	0.00504	CcSEcCtD
Deferoxamine—Leukopenia—Mesalazine—Crohn's disease	0.000363	0.00493	CcSEcCtD
Deferoxamine—Nausea—Mercaptopurine—Crohn's disease	0.000362	0.00492	CcSEcCtD
Deferoxamine—Infection—Azathioprine—Crohn's disease	0.000361	0.00491	CcSEcCtD
Deferoxamine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000356	0.00484	CcSEcCtD
Deferoxamine—Skin disorder—Azathioprine—Crohn's disease	0.000353	0.0048	CcSEcCtD
Deferoxamine—Arthralgia—Mesalazine—Crohn's disease	0.000345	0.00469	CcSEcCtD
Deferoxamine—Myalgia—Mesalazine—Crohn's disease	0.000345	0.00469	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000343	0.00466	CcSEcCtD
Deferoxamine—Hypotension—Azathioprine—Crohn's disease	0.00034	0.00462	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000331	0.0045	CcSEcCtD
Deferoxamine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000331	0.0045	CcSEcCtD
Deferoxamine—Oedema—Mesalazine—Crohn's disease	0.000331	0.0045	CcSEcCtD
Deferoxamine—Infection—Mesalazine—Crohn's disease	0.000329	0.00447	CcSEcCtD
Deferoxamine—Shock—Mesalazine—Crohn's disease	0.000326	0.00443	CcSEcCtD
Deferoxamine—Nervous system disorder—Mesalazine—Crohn's disease	0.000325	0.00441	CcSEcCtD
Deferoxamine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000324	0.00441	CcSEcCtD
Deferoxamine—Tachycardia—Mesalazine—Crohn's disease	0.000323	0.00439	CcSEcCtD
Deferoxamine—Skin disorder—Mesalazine—Crohn's disease	0.000321	0.00437	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000314	0.00426	CcSEcCtD
Deferoxamine—Hypotension—Mesalazine—Crohn's disease	0.000309	0.0042	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000302	0.0041	CcSEcCtD
Deferoxamine—Paraesthesia—Mesalazine—Crohn's disease	0.000297	0.00404	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000297	0.00404	CcSEcCtD
Deferoxamine—Dyspnoea—Mesalazine—Crohn's disease	0.000295	0.00401	CcSEcCtD
Deferoxamine—Abdominal pain—Azathioprine—Crohn's disease	0.000287	0.0039	CcSEcCtD
Deferoxamine—Body temperature increased—Azathioprine—Crohn's disease	0.000287	0.0039	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000286	0.00388	CcSEcCtD
Deferoxamine—Pain—Mesalazine—Crohn's disease	0.000283	0.00385	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000271	0.00368	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000269	0.00366	CcSEcCtD
Deferoxamine—Hypersensitivity—Azathioprine—Crohn's disease	0.000268	0.00364	CcSEcCtD
Deferoxamine—Urticaria—Mesalazine—Crohn's disease	0.000263	0.00357	CcSEcCtD
Deferoxamine—Body temperature increased—Mesalazine—Crohn's disease	0.000262	0.00356	CcSEcCtD
Deferoxamine—Abdominal pain—Mesalazine—Crohn's disease	0.000262	0.00356	CcSEcCtD
Deferoxamine—Bradycardia—Prednisone—Crohn's disease	0.000251	0.00341	CcSEcCtD
Deferoxamine—Diarrhoea—Azathioprine—Crohn's disease	0.000249	0.00338	CcSEcCtD
Deferoxamine—Hallucination—Prednisone—Crohn's disease	0.000245	0.00333	CcSEcCtD
Deferoxamine—Hypersensitivity—Mesalazine—Crohn's disease	0.000244	0.00331	CcSEcCtD
Deferoxamine—Connective tissue disorder—Prednisone—Crohn's disease	0.000242	0.00329	CcSEcCtD
Deferoxamine—Dizziness—Azathioprine—Crohn's disease	0.00024	0.00327	CcSEcCtD
Deferoxamine—Pruritus—Mesalazine—Crohn's disease	0.000234	0.00318	CcSEcCtD
Deferoxamine—Vomiting—Azathioprine—Crohn's disease	0.000231	0.00314	CcSEcCtD
Deferoxamine—Eye disorder—Prednisone—Crohn's disease	0.00023	0.00313	CcSEcCtD
Deferoxamine—Headache—Azathioprine—Crohn's disease	0.000228	0.00309	CcSEcCtD
Deferoxamine—Diarrhoea—Mesalazine—Crohn's disease	0.000226	0.00308	CcSEcCtD
Deferoxamine—Angiopathy—Prednisone—Crohn's disease	0.000224	0.00304	CcSEcCtD
Deferoxamine—Immune system disorder—Prednisone—Crohn's disease	0.000223	0.00303	CcSEcCtD
Deferoxamine—Arrhythmia—Prednisone—Crohn's disease	0.00022	0.00299	CcSEcCtD
Deferoxamine—Dizziness—Mesalazine—Crohn's disease	0.000219	0.00298	CcSEcCtD
Deferoxamine—Nausea—Azathioprine—Crohn's disease	0.000216	0.00293	CcSEcCtD
Deferoxamine—Erythema—Prednisone—Crohn's disease	0.000215	0.00292	CcSEcCtD
Deferoxamine—Vomiting—Mesalazine—Crohn's disease	0.00021	0.00286	CcSEcCtD
Deferoxamine—Headache—Mesalazine—Crohn's disease	0.000207	0.00282	CcSEcCtD
Deferoxamine—Vision blurred—Prednisone—Crohn's disease	0.000202	0.00275	CcSEcCtD
Deferoxamine—Nausea—Mesalazine—Crohn's disease	0.000197	0.00267	CcSEcCtD
Deferoxamine—Angioedema—Prednisone—Crohn's disease	0.000196	0.00267	CcSEcCtD
Deferoxamine—Convulsion—Prednisone—Crohn's disease	0.000186	0.00253	CcSEcCtD
Deferoxamine—Arthralgia—Prednisone—Crohn's disease	0.000183	0.00248	CcSEcCtD
Deferoxamine—Myalgia—Prednisone—Crohn's disease	0.000183	0.00248	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000181	0.00247	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisone—Crohn's disease	0.000175	0.00238	CcSEcCtD
Deferoxamine—Oedema—Prednisone—Crohn's disease	0.000175	0.00238	CcSEcCtD
Deferoxamine—Infection—Prednisone—Crohn's disease	0.000174	0.00236	CcSEcCtD
Deferoxamine—Shock—Prednisone—Crohn's disease	0.000172	0.00234	CcSEcCtD
Deferoxamine—Nervous system disorder—Prednisone—Crohn's disease	0.000172	0.00233	CcSEcCtD
Deferoxamine—Tachycardia—Prednisone—Crohn's disease	0.000171	0.00232	CcSEcCtD
Deferoxamine—Skin disorder—Prednisone—Crohn's disease	0.00017	0.00231	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00016	0.00217	CcSEcCtD
Deferoxamine—Paraesthesia—Prednisone—Crohn's disease	0.000157	0.00214	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000143	0.00195	CcSEcCtD
Deferoxamine—Urticaria—Prednisone—Crohn's disease	0.000139	0.00189	CcSEcCtD
Deferoxamine—Abdominal pain—Prednisone—Crohn's disease	0.000138	0.00188	CcSEcCtD
Deferoxamine—Body temperature increased—Prednisone—Crohn's disease	0.000138	0.00188	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisone—Crohn's disease	0.000129	0.00175	CcSEcCtD
Deferoxamine—Pruritus—Prednisone—Crohn's disease	0.000124	0.00168	CcSEcCtD
Deferoxamine—Diarrhoea—Prednisone—Crohn's disease	0.00012	0.00163	CcSEcCtD
Deferoxamine—Dizziness—Prednisone—Crohn's disease	0.000116	0.00157	CcSEcCtD
Deferoxamine—Vomiting—Prednisone—Crohn's disease	0.000111	0.00151	CcSEcCtD
Deferoxamine—Headache—Prednisone—Crohn's disease	0.00011	0.00149	CcSEcCtD
Deferoxamine—Nausea—Prednisone—Crohn's disease	0.000104	0.00141	CcSEcCtD
